Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gemcitabine Plus Capecitabine Versus Gemcitabine Alone In Advanced Pancreatic Cancer. A Randomized Phase III Trial

NCT00030732 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00030732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00030732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gemcitabine Plus Capecitabine Versus Gemcitabine Alone In Advanced Pancreatic Cancer. A Randomized Phase III Trial
Lead sponsor
Swiss Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2001
Completion date
April 30, 2008
Enrollment
319 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer